We are pleased to announce the first ResIn publication covering UK cancer research investments. It is published in BMJ Open, and the full open-access publication can be found by clicking here.
We assessed thousands of research projects covering all types of cancer, and identify areas of research strength in the UK and areas where the portfolio is relatively weak. Breast and prostate cancers, for example, received relatively high investment compared to burden of disease whilst there was little funding for cancer of the liver, thyroid, lung, upper GI tract and bladder, despite high burdens of disease. Around two-thirds of the investment is for pre-clinical science.